BCORL1 and myelodysplastic syndrome: Bernard et al. performed genomic profiling of 3233 patients with adult MDS and identified 3.5% (n = 114) of patients as having mutations in BCOR (85%), 33% as having those in BCORL1, and 17% as having those in both genes.